Flu News and Research

RSS

FluCide nanoviricide drug reduces overall leukocytes in lung tissue of influenza model

NanoViricides, Inc. reports that post-infection treatment with its optimized FluCide drug candidates resulted in significant reduction in lung tissue presence of leukocytes, and in particular, that of eosinophils in a lethal influenza infection animal model.

8 Apr 2011

Democratic Congresswoman highlights threat climate change poses to public health

Rep. Lois Capps (D-Calif.) "called climate change a bigger public health threat than AIDS, malaria and pandemic flu" before a vote on Wednesday on a bill aimed at thwarting Environmental Protection Agency climate regulations, The Hill's "E2-Wire" blog reports.

8 Apr 2011

Study: DBS surgery allows 77% of patients to stop anti-tremor medication use

Deep brain stimulation, a surgical procedure to suppress faulty nerve signals, allowed 77 percent of patients to stop the medications used to treat their essential tremors within one year following the surgery, University of South Florida researchers report.

8 Apr 2011

Quest Diagnostics Simplexa molecular test receives bronze award for best new product

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that the Simplexa™ molecular test on the 3M™ Integrated Cycler was honored with a bronze award for best new science and medical diagnostic product during the 2011 Edison Awards gala ceremony last night in New York City.

From Quest Diagnostics 7 Apr 2011

Study: Migratory birds play a key role in avian influenza transmission

The persistence and recurrence of H5N1 avian influenza in endemic regions can largely be blamed on movement and infection by migratory birds. Trade in poultry, poultry products and caged birds, and movement of wild birds also account for H5N1 prevalence in these areas.

6 Apr 2011

Genzyme, Isis present mipomersen phase 3 study data in severe heFH at ACC meeting

Genzyme Corp., a subsidiary of sanofi-aventis Group, and Isis Pharmaceuticals Inc. announced today that data from two phase 3 studies of mipomersen in patients who had high cholesterol levels while on lipid-lowering therapy were presented at the American College of Cardiology's 60th Annual Scientific Session.

6 Apr 2011

Post-infection treatment with NanoViricides FluCide reduces lung lesions caused by lethal influenza infection

NanoViricides, Inc. reports that post-infection treatment with its optimized FluCide™ drug candidates resulted in dramatic reduction in the number of lung lesions that are caused by a lethal influenza virus infection. These findings were seen in the most recent H1N1 influenza animal study.

5 Apr 2011

Jennerex, Transgene present JX-594 Phase 1 and 2 study data in liver cancer at EASL meeting

Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene,a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that new data from Phase 1 and 2 clinical studies of JX-594 were presented in an oral presentation at the 46th Annual Meeting of the European Association for the Study of the Liver over the weekend at the Internationales Congress Centrum in Berlin, Germany.

5 Apr 2011

State Roundup: Budget cuts in Texas, Wash. State; Ariz. smoking, weight fees; Coping with Rx drug abuse

The Texas House voted 98-49 Sunday night to slash funding for public schools, nursing homes and college financial aid in a dramatic show by Republicans elected on a limited-government message in the face of a massive budget shortfall.

4 Apr 2011

BMY announces PEG-Interferon lambda plus ribavirin Phase IIb trial results against HCV

Bristol-Myers Squibb Company today announced results from the Phase IIb EMERGE clinical trial, in which treatment with the investigational compound PEG-Interferon lambda and ribavirin achieved higher rates of rapid virologic response in genotypes 1, 2, 3, and 4, and complete early virologic response in genotypes 1 and 4 than the standard regimen of PEG-Interferon alfa and ribavirin in treatment-naïve patients chronically infected with hepatitis C.

4 Apr 2011

New data finds PegIFN-lambda shows RVR in HCV patients with improved safety, tolerability

Highly exciting new data presented today at the International Liver Congress found Pegylated Interferon-lambda shows superior virological response in HCV patients of genotypes 1-4, with improved safety and tolerability, compared to Pegylated Interferon-alpha, the current standard of care in chronic HCV.

4 Apr 2011

Idera's IMO-2125 plus ribavirin Phase 1 trial results against HCV presented at EASL meeting

Idera Pharmaceuticals, Inc. announced today the presentation of data from a four-week Phase 1 clinical trial of IMO-2125 in combination with ribavirin in treatment-naïve patients chronically infected with hepatitis C virus genotype 1.

2 Apr 2011

Biota Scientific receives BARDA contract to develop single-dose antiviral drug

A contract has been awarded to develop a long-acting single-dose antiviral drug for use in the United States, the U.S. Biomedical Advanced Research and Development Authority announced today.

1 Apr 2011

Biota wins U.S. drug development contract for Laninamivir

Australian biotechnology company Biota Holdings revealed its US subsidiary has won a five year $US231 million ($A224.36 million) contract from the US government to develop a long-acting, single-dose flu drug for sale in the US. Shares in the Melbourne-based drug development company jumped 60 cents, or 57%, to $1.60 at the market open today falling back to $1.43, 1pm (AEST).

31 Mar 2011

WHO Director-General responds to draft report on agency's handling of H1N1 pandemic

WHO Director-General Margaret Chan on Monday responded to the first results of a probe into the agency's response to the H1N1 pandemic, Agence France-Presse reports.

30 Mar 2011

Scientist develops new model to understand peoples' behaviors during flu outbreaks

When influenza pandemics arrive, the specter of disease spread through person-to-person contact can mean that schools close, hand sanitizer sales rise, and travellers stay home. But is severing social and business interactions with our neighbors really better than taking a chance on getting sick?

29 Mar 2011

Reports of H1N1 outbreaks in Venezuela, Mexico prompt quick preventive action by health authorities

Health officials in Venezuela announced on Friday the number of confirmed H1N1 cases in the country has grown to more than 200, the Associated Press/Seattle Times reports.

29 Mar 2011

Chembio develops DPP assay for rapid detection of HIV and HEP B/C

A kidney recipient in a New York City hospital recently contracted HIV from the transplanted organ, which came from a living donor, according to the New York State Department of Health. Although an initial screening had been performed on the donor, he or she apparently had unsafe sex after the test but before donating the kidney.

28 Mar 2011

Mexico on swine flu alert again

After four new deaths from swine flu (H1N1), authorities in Mexico's Chihuahua state along the U.S. border announced preventive health measures Sunday to staunch a return of an H1N1 epidemic.

27 Mar 2011

First evidence of H5N1 transmission between domestic farms and wild birds

Wild migratory birds may indeed play a role in the spread of bird flu, also known as highly pathogenic avian influenza H5N1.

25 Mar 2011

Flu News and Research

FluCide nanoviricide drug reduces overall leukocytes in lung tissue of influenza model

Democratic Congresswoman highlights threat climate change poses to public health

Study: DBS surgery allows 77% of patients to stop anti-tremor medication use

Quest Diagnostics Simplexa molecular test receives bronze award for best new product

Study: Migratory birds play a key role in avian influenza transmission

Genzyme, Isis present mipomersen phase 3 study data in severe heFH at ACC meeting

Post-infection treatment with NanoViricides FluCide reduces lung lesions caused by lethal influenza infection

Jennerex, Transgene present JX-594 Phase 1 and 2 study data in liver cancer at EASL meeting

State Roundup: Budget cuts in Texas, Wash. State; Ariz. smoking, weight fees; Coping with Rx drug abuse

BMY announces PEG-Interferon lambda plus ribavirin Phase IIb trial results against HCV

New data finds PegIFN-lambda shows RVR in HCV patients with improved safety, tolerability

Idera's IMO-2125 plus ribavirin Phase 1 trial results against HCV presented at EASL meeting

Biota Scientific receives BARDA contract to develop single-dose antiviral drug

Biota wins U.S. drug development contract for Laninamivir

WHO Director-General responds to draft report on agency's handling of H1N1 pandemic

Scientist develops new model to understand peoples' behaviors during flu outbreaks

Reports of H1N1 outbreaks in Venezuela, Mexico prompt quick preventive action by health authorities

Chembio develops DPP assay for rapid detection of HIV and HEP B/C

Mexico on swine flu alert again

First evidence of H5N1 transmission between domestic farms and wild birds

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News